Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Childhood-onset schizophrenia is a rare but severe form of the disorder that is often treatment-refractory. In this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia. METHODS: Twenty-one patients (mean [+/-SD] age, 14.0 +/- 2.3 years) with onset of Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition-defined schizophrenia that began by age 12 years and who had been nonresponsive to typical neuroleptics participated in the study. Patients were randomized to a 6-week double-blind parallel comparison of clozapine (mean [+/-SD] final dose, 176 +/- 149 mg/d), or haloperidol, (16 +/- 8 mg/d). RESULTS: Clozapine was superior to haloperidol on all measures of psychosis (P = .04-.002). Positive and negative symptoms of schizophrenia improved. However, neutropenia and seizures were major concerns. To date, one third of the group has discontinued using clozapine. CONCLUSIONS: Clozapine has striking superiority for positive and negative symptoms in treatment-refractory childhood-onset schizophrenia. However, due to possibly increased toxic effects in this pediatric population, close monitoring for adverse events is essential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These medications remain of major importance, including clozapine, the most effective (and toxic) of all for childhood psychosis (46,47).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [46]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Benes, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060041004 · Cited by 744
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
BUNNEY, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
Pickar, D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050009001 · Cited by 354
Treatment of the Neuroleptic-Nonresponsive Schizophrenic Patient
Meltzer, H. Y. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.3.515 · Cited by 332
Devinsky, O., Honigfeld, G., & Patin, J. (1991) · Neurology · doi:10.1212/wnl.41.3.369 · Cited by 322
Clozapine: neuroleptic-induced EPS and tardive dyskinesia
Casey, D. E. (1989) · Psychopharmacology · doi:10.1007/bf00442559 · Cited by 251
Clozapine-induced weight gain: prevalence and clinical relevance
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248
Childhood-Onset Schizophrenia: The Severity of Premorbid Course
ALAGHBAND-RAD, J., MCKENNA, K., GORDON, C. T., ALBUS, K. E., HAMBURGER, S. D., RUMSEY, J. M., FRAZIER, J. A., LENANE, M. C., & RAPOPORT, J. L. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199510000-00012 · Cited by 237
Looking for Childhood-Onset Schizophrenia: The First 71 Cases Screened
McKENNA, K., GORDON, C. T., LENANE, M., KAYSEN, D., FAHEY, K., & RAPOPORT, J. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00003 · Cited by 219
Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes
Keepers, G. A. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790090075012 · Cited by 216
Clozapine‐related seizures: Experience with 5,629 patients
Pacia, S. V., & Devinsky, O. (1994) · Neurology · doi:10.1212/wnl.44.12.2247 · Cited by 199
Brain Anatomic Magnetic Resonance Imaging in Childhood-Onset Schizophrenia
Frazier, J. A. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070065010 · Cited by 198
Childhood-Onset Schizophrenia: History of the Concept and Recent Studies
Remschmidt, H. E., Schulz, E., Martin, M., Warnke, A., & Trott, G.-E. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.4.727 · Cited by 198
Practice Parameters for the Assessment and Treatment of Children and Adolescents with Schizophrenia
McClellan, J., & Werry, J. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00002 · Cited by 197
Childhood-Onset Schizophrenia: An NIMH Study in Progress
Gordon, C. T., Frazier, J. A., McKenna, K., Giedd, J., Zametkin, A., Kaysen, D., Albus, K. E., Rapoport, J. L., Zahn, T., Hong, W., et al. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.4.697 · Cited by 187
Epidemiology of early-onset schizophrenia
Häfner, H., & Nowotny, B. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190734 · Cited by 185
Psychopharmacology in Child and Adolescent Psychiatry: A Review of the Past Five Years
CAMPBELL, M., & SPENCER, E. K. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198805000-00001 · Cited by 182
Umbricht, D., Pollack, S. Z., & Kane, J. (1994) · PubMed · Cited by 179
Schizophrenia with Childhood Onset: A Phenomenological Study of 38 Cases
GREEN, W. H., PADRON-GAYOL, M., HARDESTY, A. S., & BASSIRI, M. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199209000-00027 · Cited by 169
Patient response and resource management: another view of clozapine treatment of schizophrenia
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.827 · Cited by 161
Childhood-onset Schizophrenia: A Followup Study
Asarnow, J. R., Tompson, M. C., & Goldstein, M. J. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.4.599 · Cited by 154
Does clozapine cause tardive dyskinesia?
Kane, J. M., Woerner, M. G., Pollack, S. Z., Safferman, A. Z., & Lieberman, J. A. (1993) · PubMed · Cited by 139
An Open Trial of Clozapine in 11 Adolescents with Childhood-Onset Schizophrenia
Frazier, J. A., Gordon, C. T., McKenna, K., Lenane, M., JIH, D., & RAPOPORT, J. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00006 · Cited by 134
A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.
Pool, D., Bloom, W., Mielke, D. H., Jj, R., & Dm, G. (1976) · PubMed · Cited by 120
Children With Schizophrenia: Diagnosis, Phenomenology, and Pharmacotherapy
SPENCER, E. K., & Campbell, M. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.4.713 · Cited by 116
Gualtieri, C. T., Quade, D., Hicks, R. E., Mayo, J. P., & Schroeder, S. R. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.20 · Cited by 109
Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents
Realmuto, G. M., Erickson, W. D., Yellin, A. M., Hopwood, J. H., & Greenberg, L. M. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.3.440 · Cited by 106
Haloperidol in schizophrenic children: early findings from a study in progress.
SPENCER, E. K., Kafantaris, V., Padron-Gayol, M., Rosenberg, C. R., & Campbell, M. (1992) · PubMed · Cited by 101
Clozapine: is another view valid?
Meltzer, H. Y. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.821 · Cited by 95
Clozapine-induced seizures and EEG changes
Welch, J., Manschreck, T. C., & Redmond, D. J. (1994) · Journal of Neuropsychiatry · doi:10.1176/jnp.6.3.250 · Cited by 80
Seizures during clozapine therapy.
Devinsky, O., & Pacia, S. V. (1994) · PubMed · Cited by 76
Clozapine for the Treatment of Adolescents with Schizophrenia
Birmaher, B. B., BAKER, R., Kapur, S., Quintana, H., & Ganguli, R. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00024 · Cited by 74
Clozapine Treatment in Very Early Onset Schizophrenia
Mozes, T., Toren, P., CHERNAUZAN, N., Mester, R., Yoran‐Hegesh, R., Blumensohn, R., & Weizman, A. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199401000-00010 · Cited by 72
Autonomic Nervous System Markers of Psychopathology in Childhood-Onset Schizophrenia
Zahn, T. P., Jacobsen, L. K., Gordon, C. T., McKenna, K., Frazier, J. A., & Rapoport, J. L. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830220020003 · Cited by 69
Clozapine -- Deciphering the Risks
Gerson, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290312 · Cited by 61
Risperidone Treatment of Children and Adolescents: Increased Risk of Extrapyramidal Side Effects?
MANDOKI, M. W. (1995) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1995.5.49 · Cited by 59
Piscitelli, S. C., Frazier, J. A., McKenna, K., Albus, K. E., Grothe, D. R., Gordon, C. T., & Rapoport, J. L. (1994) · PubMed · Cited by 57
Campbell, A., Baldessarini, R. J., & Teicher, M. H. (1988) · Psychopharmacology · doi:10.1007/bf00735879 · Cited by 40
Towbin, K. E., Dykens, E. M., & PUGLIESE, R. G. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00005 · Cited by 38
Clozapine for tardive dyskinesia in adolescents
Levkovitch, Y., Kronenberg, J., Kayser, N., Zvyagelski, M., Gaoni, B., & Gadoth, N. (1995) · Brain and Development · doi:10.1016/0387-7604(95)00034-9 · Cited by 28
Dosing of Antipsychotic Agents in Pediatric Populations
Baldessarini, R. J., & Teicher, M. H. (1995) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1995.5.1 · Cited by 26
Comparison of adult manifestations of schizophrenia with onset before and after 15 years of age
Yang, P., Liu, C. ‐., Chiang, S. ‐., Chen, J. Y., & Lin, T. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb09769.x · Cited by 26
Clozapine in the Treatment of a Young Adolescent with Schizophrenia
Jacobsen, L. K., WALKER, M. C., Edwards, J. E., Chappell, P. B., & WOOLSTON, J. L. (1994) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199406000-00004 · Cited by 20
Freedman, J., Wirshing, W. C., RUSSELL, A. T., BRAY, M. P., & UNUTZER, J. (1994) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1994.4.53 · Cited by 15
Efficacy of clozapine versus haloperidol in a long-term clinical trial
Kane, J. M., Schooler, N., Marder, S. R., Wirshing, W. C., Ames, D., Umbricht, D., Safferman, A. Z., Baker, R., & Ganguli, R. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)85427-2 · Cited by 12
Fluoxetine side-effects mimicking hypoglycaemia
Lear, J. T., & Burden, A. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)91624-h · Cited by 12
Cited by
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Chakos, M., Lieberman, J., Hoffman, E., Bradford, D., & Sheitman, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.518 · Cited by 631
Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.177261 · Cited by 601
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 591
Sikich, L., Frazier, J. A., McClellan, J., Findling, R. L., Vitiello, B., Ritz, L., Ambler, D., Puglia, M., Maloney, A. E., Michael, E., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050756 · Cited by 478
Metadata
- Authors
- Kumra, S.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Kumra, Sanjiv
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-12-01
- Volume
- 53
- Issue
- 12
- Pages
- 1090
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2125778283
- Cited by
- 410
- References
- 53
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 13 · 2015: 5 · 2014: 7 · 2013: 19 · 2012: 23
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- childhood schizophrenia, clozapine, haloperidol, treatment-resistant schizophrenia, antipsychotic efficacy, adverse drug reactions, neutropenia, seizures, positive and negative symptoms, child psychiatry, atypical antipsychotics
- MeSH terms
- Adolescent, Age Factors, Child, Child, Preschool, Clozapine, Double-Blind Method, Drug Administration Schedule, Haloperidol, Humans, Neutropenia, Psychiatric Status Rating Scales, Schizophrenia, Childhood, Seizures, Severity of Illness Index, Treatment Outcome, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.